BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 19305347)

  • 1. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.
    Obstet Gynecol; 2009 Apr; 113(4):957-966. PubMed ID: 19305347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.
    Obstet Gynecol; 2017 Sep; 130(3):e110-e126. PubMed ID: 28832484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome.
    Obstet Gynecol; 2017 Sep; 130(3):657-659. PubMed ID: 28832475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
    Prucka SK; McIlvried DE; Korf BR
    Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.
    Frank TS; Deffenbaugh AM; Hulick M; Gumpper K
    Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing by cancer site: breast.
    Shannon KM; Chittenden A
    Cancer J; 2012; 18(4):310-9. PubMed ID: 22846731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.
    Robson ME
    Cancer Control; 2002; 9(6):457-65. PubMed ID: 12514563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary breast cancer and genetic counseling in young women.
    Brunet J
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():7-9. PubMed ID: 20711663
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
    Loescher LJ; Lim KH; Leitner O; Ray J; D'Souza J; Armstrong CM
    Oncol Nurs Forum; 2009 Mar; 36(2):E57-67. PubMed ID: 19273395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
    Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
    Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
    de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T
    Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects.
    Komata D; Yahata T; Kodama S; Koyama Y; Takeda N; Tajima K; Makino H; Sato N; Muto I; Hatakeyama K; Tanaka K
    J Obstet Gynaecol Res; 2009 Oct; 35(5):912-7. PubMed ID: 20149041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics: breast cancer as an exemplar.
    Hamilton R
    Nurs Clin North Am; 2009 Sep; 44(3):327-38. PubMed ID: 19683094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
    Drohan B; Roche CA; Cusack JC; Hughes KS
    Ann Surg Oncol; 2012 Jun; 19(6):1732-7. PubMed ID: 22427173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.